Analyst Price Target is $273.38
▲ +16.41% Upside Potential
This price target is based on 12 analysts offering 12 month price targets for Teleflex in the last 3 months. The average price target is $273.38, with a high forecast of $330.00 and a low forecast of $210.00. The average price target represents a 16.41% upside from the last price of $234.84.
Current Consensus is
The current consensus among 12 contributing investment analysts is to buy stock in Teleflex. This rating changed within the last month from a Hold consensus rating.
Teleflex, Inc. provides medical technology products which enables healthcare providers to improve patient outcomes and enhance patient and provider safety. The firm designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates through the following business segments: Americas, EMEA (Europe, the Middle East and Africa), Asia (Asia Pacific) and OEM. The Americas segment engages in the sales of interventional urology products. The EMEA engages in the sales of urology products. The Asia segment designs, manufactures and distributes medical devices primarily used in critical care, surgical applications and cardiac care and generally serves hospitals and healthcare providers. The OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. The company was founded in 1943 and is headquartered in Wayne, PA.